197 related articles for article (PubMed ID: 15330195)
21. Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer.
Zheng W; Xie DW; Jin F; Cheng JR; Dai Q; Wen WQ; Shu XO; Gao YT
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):147-50. PubMed ID: 10698474
[TBL] [Abstract][Full Text] [Related]
22. Polymorphisms of human estrogen receptor (ER) gene alpha and beta in prostate cancer PC-EW and PC-OR cell lines.
Bergner CC; Krause FS; Zugor V; Rith T; Schrott KM; Endele S; Engehausen DG
Anticancer Res; 2007; 27(4A):2071-4. PubMed ID: 17649823
[TBL] [Abstract][Full Text] [Related]
23. The use of genetic markers to determine risk for prostate cancer at prostate biopsy.
Nam RK; Zhang WW; Jewett MA; Trachtenberg J; Klotz LH; Emami M; Sugar L; Sweet J; Toi A; Narod SA
Clin Cancer Res; 2005 Dec; 11(23):8391-7. PubMed ID: 16322300
[TBL] [Abstract][Full Text] [Related]
24. Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk.
Singal R; Ferdinand L; Das PM; Reis IM; Schlesselman JJ
Int J Oncol; 2004 Nov; 25(5):1465-71. PubMed ID: 15492840
[TBL] [Abstract][Full Text] [Related]
25. p53 Codon 72 and p21 codon 31 polymorphisms in prostate cancer.
Huang SP; Wu WJ; Chang WS; Wu MT; Chen YY; Chen YJ; Yu CC; Wu TT; Lee YH; Huang JK; Huang CH
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2217-24. PubMed ID: 15598783
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms of estrogen-related genes jointly confer susceptibility to human spermatogenic defect.
Su MT; Chen CH; Kuo PH; Hsu CC; Lee IW; Pan HA; Chen YT; Kuo PL
Fertil Steril; 2010 Jan; 93(1):141-9. PubMed ID: 18980759
[TBL] [Abstract][Full Text] [Related]
27. Polymorphisms in estrogen bioactivation, detoxification and oxidative DNA base excision repair genes and prostate cancer risk.
Nock NL; Cicek MS; Li L; Liu X; Rybicki BA; Moreira A; Plummer SJ; Casey G; Witte JS
Carcinogenesis; 2006 Sep; 27(9):1842-8. PubMed ID: 16569655
[TBL] [Abstract][Full Text] [Related]
28. Significance of vitamin D receptor gene polymorphism for prostate cancer risk in Japanese.
Watanabe M; Fukutome K; Murata M; Uemura H; Kubota Y; Kawamura J; Yatani R
Anticancer Res; 1999; 19(5C):4511-4. PubMed ID: 10650802
[TBL] [Abstract][Full Text] [Related]
29. Estrogen receptor gene polymorphism and generalized osteoarthritis.
Ushiyama T; Ueyama H; Inoue K; Nishioka J; Ohkubo I; Hukuda S
J Rheumatol; 1998 Jan; 25(1):134-7. PubMed ID: 9458216
[TBL] [Abstract][Full Text] [Related]
30. [Association of polymorphisms of p21cip1 and p27kip1 genes with susceptibilities of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Guo W; Cui YJ; Fang SM; Li Y; Wang N; Zhang JH
Ai Zheng; 2006 Feb; 25(2):194-9. PubMed ID: 16480585
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms in oxidative stress-related genes are not associated with prostate cancer risk in heavy smokers.
Choi JY; Neuhouser ML; Barnett M; Hudson M; Kristal AR; Thornquist M; King IB; Goodman GE; Ambrosone CB
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1115-20. PubMed ID: 17548672
[TBL] [Abstract][Full Text] [Related]
32. Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer.
Salam MT; Ursin G; Skinner EC; Dessissa T; Reichardt JK
Urol Oncol; 2005; 23(4):246-53. PubMed ID: 16018939
[TBL] [Abstract][Full Text] [Related]
33. CYP3A5 gene polymorphism and risk of prostate cancer in a Japanese population.
Zhenhua L; Tsuchiya N; Narita S; Inoue T; Horikawa Y; Kakinuma H; Kato T; Ogawa O; Habuchi T
Cancer Lett; 2005 Jul; 225(2):237-43. PubMed ID: 15876487
[TBL] [Abstract][Full Text] [Related]
34. CYP450 polymorphisms as risk factors for early-onset lung cancer: gender-specific differences.
Timofeeva MN; Kropp S; Sauter W; Beckmann L; Rosenberger A; Illig T; Jäger B; Mittelstrass K; Dienemann H; ; Bartsch H; Bickeböller H; Chang-Claude JC; Risch A; Wichmann HE
Carcinogenesis; 2009 Jul; 30(7):1161-9. PubMed ID: 19414505
[TBL] [Abstract][Full Text] [Related]
35. Estrogen receptor polymorphisms and the risk of endometrial cancer.
Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Gilbert M; Hamann U; Scott RJ
BJOG; 2009 Jul; 116(8):1053-61. PubMed ID: 19438492
[TBL] [Abstract][Full Text] [Related]
36. Genetic variants in the vitamin D receptor gene and prostate cancer risk.
Hayes VM; Severi G; Padilla EJ; Eggleton SA; Southey MC; Sutherland RL; Hopper JL; Giles GG
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):997-9. PubMed ID: 15824177
[TBL] [Abstract][Full Text] [Related]
37. [Case-control study of the genes of receptors of the androgens of vitamin-D and of 5-alphareductase in a population of Afro-Caribbean population with prostate cancer].
Veronique-Baudin J; Dieye M; Kouyoumdjian JC; Vacheron F; Draganescu C; Azaloux H
Prog Urol; 2006 Jun; 16(3):303-10. PubMed ID: 16821341
[TBL] [Abstract][Full Text] [Related]
38. Susceptibility to lung cancer and genetic polymorphisms in the alcohol metabolite-related enzymes alcohol dehydrogenase 3, aldehyde dehydrogenase 2, and cytochrome P450 2E1 in the Japanese population.
Minegishi Y; Tsukino H; Muto M; Goto K; Gemma A; Tsugane S; Kudoh S; Nishiwaki Y; Esumi H
Cancer; 2007 Jul; 110(2):353-62. PubMed ID: 17559142
[TBL] [Abstract][Full Text] [Related]
39. Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma.
Wheatley-Price P; Asomaning K; Reid A; Zhai R; Su L; Zhou W; Zhu A; Ryan DP; Christiani DC; Liu G
Cancer; 2008 Mar; 112(5):1037-42. PubMed ID: 18205184
[TBL] [Abstract][Full Text] [Related]
40. Impact of IGF-I and CYP19 gene polymorphisms on the survival of patients with metastatic prostate cancer.
Tsuchiya N; Wang L; Suzuki H; Segawa T; Fukuda H; Narita S; Shimbo M; Kamoto T; Mitsumori K; Ichikawa T; Ogawa O; Nakamura A; Habuchi T
J Clin Oncol; 2006 May; 24(13):1982-9. PubMed ID: 16648498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
